Record Details

Economic impact of the use of Hyalubrix® in the treatment of hip osteoarthritis in Italy

Farmeconomia

View Archive Info
 
 
Field Value
 
Title Economic impact of the use of Hyalubrix® in the treatment of hip osteoarthritis in Italy
 
Creator Migliore, Alberto
Belisari, Andrea
D'Angiolella, Lucia S.
Bizzi, Emanuele
Massafra, Umberto
Piscitelli, Prisco
Mantovani, Lorenzo Giovanni
 
Subject
Hyaluronic acid; Coxarthrosis; Ultrasound-guided intra-articular injection
 
Description The present study aims at evaluating the economic impact of the use of hyaluronic acid (Hyalubrix®60/HyalOne) as an alternative to surgery in the treatment of hip osteoarthritis, consistently with the therapeutic protocol envisaged in the Ortobrix study. To quantify the cost and efficacy of the treatment options under evaluation, the perspective of both the Italian NHS and the Society was considered. To this end, a decision analysis model was created over a 4-year period, to quantify the cost of treatments, procedures and adverse events, as well as the benefits expressed as survival rates and reduced lost workdays. The results show that, since the treatment with Hyalubrix® enables to avoid or delay the need for Total Hip Replacement (THR) surgery, it is possible to reduce mortality, adverse events and total costs. Hyalubrix®, given in the hip by ultrasound-guided intra-articular injection as an alternative to surgery is the most favourable option, helping preserve the survival rate over a 4-year period, of approximately 1 in 100 patients considered candidates for THR, preserve work capacity for a total differential amount of 500 days, and achieve considerable savings in economic terms, of approximately 550,000 € and 600,000€ euros from the NHS and the Societal perspectives, respectively.
 
Publisher SEEd
 
Contributor Fidia Farmeceutici
 
Date 2014-12-23
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

 
Format text/html
application/pdf
 
Identifier http://journals.edizioniseed.it/index.php/FE/article/view/977
10.7175/fe.v15i4.977
 
Source Farmeconomia. Health economics and therapeutic pathways; Vol 15, No 4 (2014); 139-146
2240-256X
1721-6915
 
Language eng
 
Relation http://journals.edizioniseed.it/index.php/FE/article/view/977/1190
http://journals.edizioniseed.it/index.php/FE/article/view/977/1191
 
Coverage